Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules

Abstract

Abstract is not available.

Similar works

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.